Clinical Trials on Cryoglobulinemic Vasculitis (CV)

Total 711 results

Matthias Fröhlich

Completed

CXCR4-PET/CT for Diagnosing Giant Cell Arteritis

Vasculitis | Diagnoses Disease

Germany
AbbVie

Terminated

A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154 (AIM-PMR)

Polymyalgia Rheumatica

United States, Australia, Austria, Canada, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Spain, United Kingdom
University Hospital, Brest
Bristol-Myers Squibb

Active, not recruiting

Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS (ALORS)

Polymyalgia Rheumatica

France
Matthew J Koster
Eli Lilly and Company

Completed

Baricitinib in Relapsing Giant Cell Arteritis

Arteritis, Giant Cell

United States
Novartis Pharmaceuticals

Terminated

A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica

Polymyalgia Rheumatica | Inflammatory Diseases

Germany, Italy, United States, United Kingdom
Medical University of Vienna

Completed

A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)

Polymyalgia Rheumatica

Austria
Royal North Shore Hospital

Completed

Giant Cell Arteritis and PET Scan (GAPS) Study

Giant Cell Arteritis

Australia
Centre Hospitalier Universitaire Dijon

Completed

Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's Disease (ACG et TREG)

Horton's Disease

France
Hoffmann-La Roche

Completed

An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA)

Giant Cell Arteritis

United States, United Kingdom, Sweden, Belgium, Netherlands, Germany, Spain, Norway, Poland, France, Italy, Canada, Denmark, Portugal
Peking University People's Hospital

Unknown

Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica

Polymyalgia Rheumatica
GlaxoSmithKline

Terminated

Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis

Giant Cell Arteritis

United States, Spain, Germany, Italy, Belgium, France, Netherlands, Australia, United Kingdom, Hungary, Poland, Bulgaria, New Zealand
University Hospital, Grenoble

Terminated

Biomarkers in Giant Cells Arteritis (BioACG)

Giant Cells Arteritis

France
University Hospital Inselspital, Berne
Roche Pharma AG; University of Bern

Completed

Tocilizumab for Patients With Giant Cell Arteritis

Giant Cell Arteritis

Switzerland
Mundipharma Research Limited

Terminated

A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR

Polymyalgia Rheumatica

United Kingdom
GlaxoSmithKline

Withdrawn

Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica

Polymyalgia Rheumatica
Dinora, Inc.
PharPoint Research, Inc.; Analgesic Solutions

Terminated

Delayed Release Prednisone in PMR

Polymyalgia Rheumatica

United States
University of Oxford
University of Lisbon

Unknown

Giant Cell Arteritis: Improving Use of Ultrasound Evaluation (GAULT)

Giant Cell Arteritis
University of Oxford
London School of Hygiene and Tropical Medicine; The Leeds Teaching Hospitals... and other collaborators

Completed

Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL) (TABUL)

Giant Cell Arteritis

Ireland, United Kingdom, Germany, Norway, Portugal
University Hospital, Brest
Chugai Pharmaceutical

Completed

Tocilizumab Effect iN pOlymyalgia Rheumatica (TENOR)

Polymyalgia Rheumatica

France
University Hospital, Caen

Unknown

Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis (PREDICORT)

Giant Cell Arteritis

France
Bispebjerg Hospital

Completed

Etanercept Treatment in the Early Course of Polymyalgia Rheumatica

Polymyalgia Rheumatica

Denmark
Fondation Ophtalmologique Adolphe de Rothschild

Completed

TransIent Perivascular Inflammation of the Carotid Artery (TIPIC) Syndrome: Clinical and Radiological Follow-up (TIPIC-UNV)

Vasculitis | Cervical Pain

France
Centre Hospitalier Universitaire de Saint Etienne

Completed

POST (Prospective Observational Superfial Thrombophlebitis) (POST)

Thrombophlebitis

France
University of Health Sciences Lahore

Not yet recruiting

Comparison of Magnesium Sulphate Versus Cold Compress in IV Cannula Induces Phlebitis

Patient With IV Cannula Induce Phlebitis
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis

Thrombophlebitis

Italy
University Hospital Muenster

Completed

Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.

Sepsis | Pre-Eclampsia | Adiposity | Microscopic Polyangiitis | Granulomatosis With Polyangiitis | SIRS | Procalcitonin

Germany
Shandong Provincial Institute of Dermatology and...
Shandong Provincial Hospital; Jinan Military General Hospital; Jinan Central... and other collaborators

Unknown

Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome

Psoriasis | Urticaria | Acne | Leprosy | Pneumocystis Pneumonia | Allergic Cutaneous Vasculitis | Bullous Skin Diseases | Sterile Pustulosis

China
Priscilla Hsue, MD
University of California, Los Angeles; University of Utah

Withdrawn

Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial

HIV Infection | Inflammation | Cardiovascular Disease

United States
Novartis Pharmaceuticals

Recruiting

Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission (GigAINt)

Giant Cell Arteritis

Germany
Centre Hospitalier Universitaire Dijon

Recruiting

Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis (ULTRA)

Patients Relapsing Refractory Giant Cell Arteritis

France
Novartis Pharmaceuticals

Active, not recruiting

Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)

Giant Cell Arteritis (GCA)

United States, Belgium, Hungary, Italy, Turkey, Austria, Spain, Switzerland, France, Germany, Israel, Australia, Denmark, Greece, United Kingdom, Guatemala, Bulgaria, Czechia, Estonia, Argentina, Canada, Brazil, Sweden, Finland, Poland, P... and more
RenJi Hospital

Completed

Tofacitinib as a GC Sparing Agent for Polymyalgia Rheumatica

Polymyalgia Rheumatica | Safety Issues | Effect of Drug

China
University Hospital, Limoges

Terminated

Pilot Study of the Impact of Giant Cell Arteritis and Its Treatment on the Autonomy of the Elderly in the First Year of Care (EPACAPA)

Giant Cell Arteritis in Dependency of Elderly

France
University Hospital, Limoges

Active, not recruiting

Chewing Gum Test for the Diagnosis of Giant Cell Arteritis (Horton's Disease) - ChewingHort (ChewingHort)

Horton Disease

France
Fondation Ophtalmologique Adolphe de Rothschild

Terminated

Interest of Medical Imaging in the Diagnostic Strategy Vis a Vis a Suspected Horton Disease (HORTIM)

Horton Disease

France
Svendborg Hospital
Odense University Hospital

Unknown

Polymyalgia Rheumatica and Giant Cell Arteritis

Giant Cell Arteritis | Polymyalgia Rheumatica

Denmark
China National Center for Cardiovascular Diseases

Recruiting

Biomarkers of Isolated Coronary Arteritis and Related Pathogenic Mechanism

Coronary Artery Disease | Arteritis

China
Region Skane

Completed

Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response (Vaccimil)

Syndrome | Vasculitis | SLE | Scleroderma | RA | Sjögrens

Sweden
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation

Coronary Disease | Atherosclerosis | Vasculitis

United States
Icahn School of Medicine at Mount Sinai
Gilead Sciences

Completed

Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia

Hepatitis C | Cryoglobulinemia

United States
Jagiellonian University

Terminated

Analgesic Effect of rTMS in Vasculitic Neuropathy

Vasculitic Neuropathy

Poland
University of Pennsylvania

Recruiting

Longitudinal Study for Relapsing Polychondritis

Vasculitis | Relapsing Polychondritis

United States
Baptist Health South Florida

Terminated

The Impact of Neut During Potassium Chloride Replacement on Pain and Incidence of Phlebitis (Neut-WKBH)

Hypokalemia

United States
Nagoya University

Unknown

TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation

Buerger Disease | Arteriosclerosis Obliterans

Japan
Jie Zhong

Not yet recruiting

Intraoperative Application of Fluorescein Sodium Angiography in Vascular Retinopathy

Diabetic Retinopathy | Retinal Vein Occlusion | Vitreous Hemorrhage | Retinal Vasculitis | Vascular Retinopathy of Left Eye (Disorder) | Vascular Retinopathy of Right Eye (Disorder)
University of Bonn

Recruiting

Investigation of the Influence of the Human Microbiome on Giant Cell Arteritis (GCA-Biom)

Giant Cell Arteritis

Germany
University Hospital, Basel, Switzerland
Novartis; Schweizerische Stiftung für die Erforschung der Muskelkrankheiten

Recruiting

Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis

Polymyalgia Rheumatica (PMR) | Giant Cell Arteritis (GCA)

Switzerland
Novartis Pharmaceuticals

Completed

A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis (TitAIN)

Giant Cell Arteritis

Germany
Centre Hospitalier Universitaire de Nīmes

Completed

Collection and Analysis of the Clinical and Biological Characteristics of Patients Treated for Giant Cells ARTEitis (Horton's Disease) (CARTECEL)

Giant Cell Arteritis | Horton Disease

France
University Hospital, Brest

Completed

Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica (TENOR-IMMUNO)

Polymyalgia Rheumatica

France

Clinical Trials on Cryoglobulinemic Vasculitis (CV)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations